A Brief Intervention by Nurses to Reduce the Prescribing of Occluded Peripheral Venous Catheters in the Emergency Department (PERFEKTO)
Peripheral venous catheters are frequently inserted in hospitals, with approximately 25 million placed annually in France (HAS data, 2005). The occluded peripheral venous catheter with extension tubing has become the standard in some emergency departments, offering advantages such as patient mobility, the ability to perform repeated blood draws, and the administration of intravenous medications. A 2018 meta-analysis revealed that one in three devices was unnecessary. The placement of a occluded peripheral venous is associated with a more painful insertion, higher cost, and an increased risk of infection and thromboembolism, and blood samples obtained via the occluded peripheral venous catheter are more often hemolyzed than those obtained by direct venipuncture.
Communication between physicians and nurses is essential to ensure optimal patient care. A brief intervention by the nurse when a physician prescribes a occluded peripheral venous catheter can help clarify the appropriateness of this prescription, which could lead to reduced pain for the patient, time savings for healthcare providers, and material cost savings for the hospital.
研究概览
地位
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Jessica BORTZMEYER, nurse
- 电话号码:+33 02.32.88.89.90
- 邮箱:jessica.bortzmeyer@chu-rouen.fr
研究联系人备份
- 姓名:ROUSSEL Mélanie, MD
- 邮箱:melanie.roussel@chu-rouen.fr
学习地点
-
-
-
Amiens、法国、80 000
- CHU Amiens
-
接触:
- Emilen ARNAUD
- 邮箱:Arnaud.emilien@chu-amiens.fr
-
Angers、法国、49 100
- CHU Angers
-
接触:
- Vanessa TOULIER
- 邮箱:Vanessa.toulier@chu-angers.fr
-
Clermont-Ferrand、法国、63 000
- Chu Clermont Ferrand
-
接触:
- Dorian TEISSANDIER
- 邮箱:dteissandier@chu-clermontferrand.fr
-
Créteil、法国、94 010
- APHP Henri Mondor
-
接触:
- Christian Kassasseya
- 邮箱:Christian.kassasseya@aphp.fr
-
Dieppe、法国、76 202
- Ch Dieppe
-
接触:
- Xavier LAKERMANCE
- 邮箱:xlakermance@ch-dieppe.fr
-
Eaubonne、法国、95 600
- APHP CH Simone Veil
-
接触:
- Diarra SYLLAH
- 邮箱:Diarrah.sylla@ch-simoneveil.fr
-
Lyon、法国、69 495
- HCL Lyon Sud
-
接触:
- Marion DOUPLAT
- 邮箱:marion.douplat@chu-lyon.fr
-
Marseille、法国、13013
- HIA Laveran Marseille
-
接触:
- Nicolas CAZES
- 邮箱:Nicolas.cazes@intradef.gouv.fr
-
Nancy、法国、54 000
- CHRU NANCY
-
接触:
- Tahar CHOUIHED
- 邮箱:t.choulhed@chru-nancy.fr
-
Nantes、法国、44 093
- CHU Nantes
-
接触:
- François JAVAUDIN
- 邮箱:Francoi.javaudin@chu-nantes.fr
-
Paris、法国、75 010
- APHP Lariboisière
-
接触:
- Anthony CHAUVIN
- 邮箱:Anthony.chauvin@aphp.fr
-
Paris、法国、75 013
- AP HP Pitié Salpétrière
-
接触:
- Amélie VROMANT
- 邮箱:amelie.vromant@aphp.fr
-
Paris、法国、75 018
- APHP Bichat
-
接触:
- Donia BOUZID
- 邮箱:Donia.bouzid@aphp.fr
-
Paris、法国、76 012
- APHP St Antoine
-
接触:
- Florent NOEL
- 邮箱:Florent.noel@aphp.fr
-
Rouen、法国、76 031
- CHU de Rouen
-
接触:
- Jessica BORTZMEYER
- 邮箱:jessica.bortzmeyer@chu-rouen.fr
-
Toulouse、法国、31 300
- CHU Toulouse
-
接触:
- Thomas PARDON
- 邮箱:Pardon.t@toulouse.fr
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Patients assigned a triage score of 3A, 3B, or 4 according to the French triage scale, or 3 or 4 according to the CIMU triage scale, by the triage nurse
- Patients with a blood draw order involving the placement of an occluded catheter
- Age 18 years or older
- Patients who have read and understood the information sheet
- Patients who have given their verbal consent to participate in the study
- Patients enrolled in a social security program
Exclusion Criteria:
- Patients admitted to the emergency department with a pre-existing intravenous line
- Patients treated by the Mobile Emergency and Resuscitation Unit outside the hospital
- Patients with a blocked catheter who did not undergo an initial blood draw
- Patient with known neurocognitive disorders incompatible with informed consent
- Pregnant or breastfeeding woman
- Patient under legal guardianship (guardianship or conservatorship) or patient deprived of liberty
- Patient refusing to participate in the study
- Patient participating in another interventional research study
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:不适用
- 介入模型:顺序分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Questions for the prescriber
Once the nurse has received the doctor's order for a blood draw with a KTO, she will ask the prescribing physician: Is the KTO being prescribed for: the administration of medication?
The injection of a contrast agent?
A second blood draw?
For each question, there are three possible answers: Yes? No? Maybe?
|
Once the nurse has received the doctor's order for a blood draw with a KTO, she will ask the prescribing physician: Is the KTO being prescribed for: the administration of medication?
The injection of a contrast agent?
A second blood draw?
For each question, there are three possible answers: Yes? No? Maybe?
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
the proportion of obturator catheters placed improperly
大体时间:day 1
|
Questions for the prescriber
|
day 1
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Correlation between the physician's final decision and nurse activity
大体时间:day 1
|
Correlation between the physician's final decision and the performance of a repeat biopsy, the administration of contrast dye, or the administration of intravenous treatment
|
day 1
|
|
Use of the numerical pain scale during obturator catheter placement
大体时间:at the end of procedure (assessed up to 20 minutes)
|
pain during obturator catheter placement
|
at the end of procedure (assessed up to 20 minutes)
|
|
Micro-costing analysis
大体时间:at the end of procedure (assessed up to 20 minutes)
|
Micro-costing analysis of the cost of a standard venous blood draw and a closed-catheter procedure
|
at the end of procedure (assessed up to 20 minutes)
|
|
Types of intravenous medications administered
大体时间:day 1
|
Types of intravenous medications administered and available oral alternatives
|
day 1
|
|
Number of orders for obturator catheters
大体时间:day 1
|
Number of orders for obturator catheters placement during the initial blood draw for each period throughout the entire enrollment period
|
day 1
|
合作者和调查者
调查人员
- 学习椅:Déborah LEBEDIEFF, MS、University Hospital, Rouen
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2023/0302/HP
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.